Is a complete SHE/301290 research report available?

No complete published report is available for she/301290 (SHE/301290) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

she/301290 stock profile: metrics, valuation and analysis

Market cap	2.6B
Revenue (ttm)	384.5M
Net income (ttm)	-34.1M
EPS (ttm)	-CN¥0.35
Shares out	98.7M
Dividend	CN¥0.30 (1.05%)
Volume	1,911,500
Beta	0.70

All SHE/301290 indicators

Market & fundamental data

Available fields

208

Groups with data

Currency

CNY

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	727
Employees Change	24%
Employees Change Percent	3.41
Enterprise value	CNY 1.5B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Medical Devices
Industry PE	37.44
Industry PE Fwd	23.96
Isin	CNE1000065F2
Last refreshed	2026-09-13
Market cap	CNY 2.6B
Price	CNY 26.6
Price currency	CNY
Rev Per Employee	528,886.86x
Sector	Healthcare
Sector PE	39.22
Sector PE Fwd	20.33
Sic	3845
Symbol	she/301290
Website	https://www.dx-med.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.3%
EV/EBIT	30x
EV/EBITDA	16.42x
EV/FCF	33.63x
EV/Sales	3.87x
FCF yield	1.69%
P/B ratio	1.22x
P/S ratio	6.83x
PE Ratio3 Y	26.22x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.91%
EBITDA Margin	23.46%
FCF margin	11.51%
Gross margin	48.68%
Gross Profit	CNY 187.2M
Gross Profit Growth	-5.56%
Gross Profit Growth Q	-17.54%
Gross Profit Growth3 Y	-4.14%
Gross Profit Growth5 Y	3.52%
Net Income	CNY -34.1M
Net Income Growth Q	-11.02%
Net Income Growth Qo Q	-9.47%
Pretax Margin	-5.95%
Profit Margin	-8.87%
Profit Per Employee	CNY -46,900
ROA	1.28
Roa5y	3.04
ROCE	2.28
ROE	-1.65
Roe5y	4.79
ROIC	4.83
Roic5y	7.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-2.71%
Cagr3y	-3.25%
EPS Growth Q	-5.53
EPS Growth Qo Q	-5.67
FCF Growth	287.28%
FCF Growth Q	3.83%
FCF Growth3 Y	50.69%
FCF Growth5 Y	6.94%
OCF Growth	28.17%
OCF Growth Q	25.23%
OCF Growth3 Y	-2.51%
OCF Growth5 Y	15.05%
Revenue Growth	-5.11x
Revenue Growth Q	-14.53x
Revenue Growth Qo Q	-0.71x
Revenue Growth3 Y	-3.8x
Revenue Growth5 Y	5.4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.16
Assets	CNY 2.4B
Cash	CNY 1.3B
Current Assets	CNY 1.5B
Current Liabilities	CNY 206M
Debt	CNY 109.9M
Debt EBITDA	CNY 1.21
Debt Equity	CNY 0.05
Debt FCF	CNY 2.48
Equity	CNY 2.2B
Interest Coverage	31.83
Liabilities	CNY 221.7M
Long Term Assets	CNY 922.9M
Long Term Liabilities	CNY 15.7M
Net Cash	CNY 1.1B
Net Cash By Market Cap	CNY 43.52
Net Cash Growth	3.02%
Net Debt EBITDA	CNY -12.66
Net Debt Equity	CNY -0.53
Net Debt FCF	CNY -25.8
Tangible Book Value	CNY 1.7B
Tangible Book Value Per Share	CNY 16.81
WACC	7.79

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.08
Inventory Turnover	1.67
Net Working Capital	CNY 107.5M
Quick ratio	6.47
Working Capital	CNY 1.3B
Working Capital Turnover	CNY 0.31

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.11%
Dividend Growth	-50%
Dividend Growth Years	0%
Dividend per share	CNY 0.3
Dividend Years	4
Dividend Yield	1.05%
Ex Div Date	2026-06-10
Last Dividend	CNY 0.3
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-2.71%
200-day SMA	28.01
3Y total return	-9.44%
50-day SMA	27.31
50-day SMA vs 200-day SMA	50under200
All Time High	59
All Time High Change	-54.92%
All Time High Date	2022-11-30
All Time Low	16.6
All Time Low Change	60.24%
All Time Low Date	2024-02-06
ATR	0.97
Beta	0.7
Beta1y	0.48
Beta2y	0.57
Ch YTD	5.26
High	27.27
High52	37.08
High52 Date	2026-05-11
High52ch	-28.26%
Low	26.2
Low52	21.6
Low52 Date	2026-07-21
Low52ch	23.15%
Ma50ch	-2.61%
Price vs 200-day SMA	-5.02%
RSI	37.99
RSI Monthly	45.27
RSI Weekly	46.14
Sharpe ratio	-0x
Sharpe Ratio3y	-0x
Sortino ratio	0.15
Sortino Ratio3y	0.14
Total Return	3.16%
Tr YTD	6.3
Tr1m	-8.53%
Tr1w	-5.3%
Tr3m	-12.33%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	58,258,105%
Net Borrowing	18,231,906
Shares Insiders	35.25%
Shares Institutions	10.09%
Shares Out	98,680,683
Shares Qo Q	-4.02%
Shares Yo Y	-2.11%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,717,493.9x
Bv Per Share	21.81
CAPEX	CNY -55.1M
Ch1m	-8.53
Ch1w	-5.3
Ch1y	-3.66
Ch3m	-12.33
Ch3y	-15.04
Ch6m	-6.57
Change	-2.88%
Change From Open	-1.88
Close	27.39
Days Gap	-1.02
Depreciation Amortization	40,575,600
Dollar Volume	50,845,900
Earnings Date	2026-08-24
EBIT	CNY 49.6M
EBITDA	CNY 90.2M
EPS	CNY -0.35
F Score	4
FCF	CNY 44.3M
FCF EV Yield	2.97x
FCF Per Share	CNY 0.45
Financing CF	-12,782,181
Fiscal Year End	December
Founded	2,001
Goodwill	434,211,850
Income Tax	CNY 13.4M
Investing CF	42,894,288
Is Primary Listing	1
Last Earnings Date	2026-08-24
Last Report Date	2026-06-30
Ma150	28.49
Ma150ch	-6.62%
Ma20	28.59
Ma20ch	-6.95%
Net CF	128,919,636
Next Earnings Date	2026-10-23
Open	27.11
P FCF Ratio	59.29
P OCF Ratio	26.41
Payment Date	2026-06-10
Position In Range	37.38
Ppne	339,336,219
Price Date	2026-09-11
Price EBITDA	CNY 29.1
Ptbv Ratio	1.58
Relative Volume	1.11x
Revenue	384,500,745x
Tax By Revenue	3.48x
Tr6m	-5.64%
Volume	1,911,500
Z Score	8.5

SHE/301290 (SHE/301290)

Price

Financial snapshot

Fair-value bridge

Latest news · SHE/301290

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHE/301290 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on SHE/301290

Frequently asked questions